Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
17
FTV Quote, Financials, Valuation and Earnings
Last price:
$51.28
Seasonality move
:
2.64%
Day range:
$50.34 - $51.31
52-week range:
$45.49 - $62.77
Dividend yield:
0.47%
P/E ratio:
22.49x
P/S ratio:
2.90x
P/B ratio:
1.70x
Volume:
4.7M
Avg. volume:
4.1M
1-year change:
-12.61%
Market cap:
$17.4B
Revenue:
$6.2B
EPS (TTM):
$2.28
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6B | $5.3B | $5.8B | $6.1B | $6.2B | |
| Revenue Growth (YoY) | 1.55% | 13.39% | 10.87% | 4.11% | 2.75% | |
| Cost of Revenues | $2B | $2.2B | $2.5B | $2.5B | $2.5B | |
| Gross Profit | $2.6B | $3B | $3.4B | $3.6B | $3.7B | |
| Gross Profit Margin | 56.29% | 57.23% | 57.73% | 59.26% | 59.87% | |
| R&D Expenses | $320.7M | $354.8M | $401.5M | $397.8M | $414M | |
| Selling, General & Admin | $1.7B | $1.8B | $2B | $2.1B | $2.2B | |
| Other Inc / (Exp) | $1.1B | -$32.1M | -$33.5M | -$19.4M | -$21.1M | |
| Operating Expenses | $2.1B | $2.2B | $2.4B | $2.5B | $2.6B | |
| Operating Income | $539.4M | $812.8M | $1B | $1.1B | $1.1B | |
| Net Interest Expenses | $148.5M | $103.2M | $98.3M | $123.5M | $152.8M | |
| EBT. Incl. Unusual Items | $1.5B | $677.5M | $873.5M | $990.8M | $969.6M | |
| Earnings of Discontinued Ops. | $161.1M | -$5.8M | -- | -- | -- | |
| Income Tax Expense | $55.5M | $63.3M | $118.3M | $125M | $136.7M | |
| Net Income to Company | $1.5B | $614.2M | $755.2M | $865.8M | $832.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.6B | $608.4M | $755.2M | $865.8M | $832.9M | |
| Basic EPS (Cont. Ops) | $4.58 | $1.64 | $2.12 | $2.46 | $2.39 | |
| Diluted EPS (Cont. Ops) | $4.49 | $1.63 | $2.10 | $2.43 | $2.36 | |
| Weighted Average Basic Share | $337.4M | $349M | $356.4M | $352.5M | $349.2M | |
| Weighted Average Diluted Share | $359M | $352.3M | $360.8M | $355.6M | $352.8M | |
| EBITDA | $2B | $1.2B | $1.4B | $1.6B | $1.7B | |
| EBIT | $1.7B | $780.7M | $971.8M | $1.1B | $1.1B | |
| Revenue (Reported) | $4.6B | $5.3B | $5.8B | $6.1B | $6.2B | |
| Operating Income (Reported) | $539.4M | $812.8M | $1B | $1.1B | $1.1B | |
| Operating Income (Adjusted) | $1.7B | $780.7M | $971.8M | $1.1B | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Revenue Growth (YoY) | 13.64% | 9.32% | 6.12% | 4.37% | -3.3% | |
| Cost of Revenues | $547.3M | $584.5M | $612.5M | $620.3M | $593.3M | |
| Gross Profit | $711.9M | $792M | $848.2M | $904.2M | $880.9M | |
| Gross Profit Margin | 56.54% | 57.54% | 58.07% | 59.31% | 59.75% | |
| R&D Expenses | $86.2M | $99.1M | $100.1M | $104.1M | $105.1M | |
| Selling, General & Admin | $428.1M | $480.6M | $507.7M | $561M | $542.2M | |
| Other Inc / (Exp) | -$51.2M | -$2.7M | -$2.5M | $38.9M | -$200K | |
| Operating Expenses | $514.3M | $579.7M | $607.8M | $665.1M | $647.3M | |
| Operating Income | $197.6M | $212.3M | $240.4M | $239.1M | $233.6M | |
| Net Interest Expenses | $27.7M | $18.8M | $32.1M | $44M | $32M | |
| EBT. Incl. Unusual Items | $118.7M | $190.8M | $205.8M | $234M | $201.4M | |
| Earnings of Discontinued Ops. | -$1.5M | -- | -- | -- | -- | |
| Income Tax Expense | $7M | $25.7M | $32.2M | $26.6M | $29.5M | |
| Net Income to Company | $111.7M | $165.1M | $173.6M | $207.4M | $171.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $110.2M | $165.1M | $173.6M | $207.4M | $171.9M | |
| Basic EPS (Cont. Ops) | $0.27 | $0.46 | $0.49 | $0.59 | $0.50 | |
| Diluted EPS (Cont. Ops) | $0.27 | $0.45 | $0.49 | $0.58 | $0.50 | |
| Weighted Average Basic Share | $338.6M | $359.3M | $353.6M | $351.7M | $341.1M | |
| Weighted Average Diluted Share | $341.7M | $368.4M | $356.5M | $356M | $344.6M | |
| EBITDA | $243.4M | $327.4M | $350.7M | $414.8M | $368.3M | |
| EBIT | $146.4M | $209.6M | $237.9M | $278M | $233.4M | |
| Revenue (Reported) | $1.3B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Operating Income (Reported) | $197.6M | $212.3M | $240.4M | $239.1M | $233.6M | |
| Operating Income (Adjusted) | $146.4M | $209.6M | $237.9M | $278M | $233.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.8B | $5.4B | $5.9B | $6.1B | $6.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.1B | $2.3B | $2.5B | $2.5B | $2.5B | |
| Gross Profit | $2.7B | $3.1B | $3.4B | $3.7B | $3.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $326.1M | $367.7M | $402.5M | $401.8M | $415M | |
| Selling, General & Admin | $1.8B | $1.9B | $2B | $2.1B | $2.2B | |
| Other Inc / (Exp) | $1.1B | $16.4M | -$33.3M | $22M | -$60.2M | |
| Operating Expenses | $2.1B | $2.3B | $2.4B | $2.5B | $2.6B | |
| Operating Income | $621.6M | $827.5M | $1B | $1.1B | $1.1B | |
| Net Interest Expenses | $137.6M | $94.3M | $111.6M | $135.4M | $140.8M | |
| EBT. Incl. Unusual Items | $1.6B | $749.6M | $888.5M | $1B | $937M | |
| Earnings of Discontinued Ops. | $172.5M | -$4.3M | -- | -- | -- | |
| Income Tax Expense | $45M | $82M | $124.8M | $119.4M | $139.6M | |
| Net Income to Company | $1.5B | $667.6M | $763.7M | $899.6M | $797.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.7B | $663.3M | $763.7M | $899.6M | $797.4M | |
| Basic EPS (Cont. Ops) | $4.76 | $1.82 | $2.14 | $2.55 | $2.30 | |
| Diluted EPS (Cont. Ops) | $4.58 | $1.80 | $2.14 | $2.53 | $2.28 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.1B | $1.3B | $1.5B | $1.6B | $1.6B | |
| EBIT | $1.7B | $843.9M | $1B | $1.2B | $1.1B | |
| Revenue (Reported) | $4.8B | $5.4B | $5.9B | $6.1B | $6.2B | |
| Operating Income (Reported) | $621.6M | $827.5M | $1B | $1.1B | $1.1B | |
| Operating Income (Adjusted) | $1.7B | $843.9M | $1B | $1.2B | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $547.3M | $584.5M | $612.5M | $620.3M | $593.3M | |
| Gross Profit | $711.9M | $792M | $848.2M | $904.2M | $880.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $86.2M | $99.1M | $100.1M | $104.1M | $105.1M | |
| Selling, General & Admin | $428.1M | $480.6M | $507.7M | $561M | $542.2M | |
| Other Inc / (Exp) | -$51.2M | -$2.7M | -$2.5M | $38.9M | -$200K | |
| Operating Expenses | $514.3M | $579.7M | $607.8M | $665.1M | $647.3M | |
| Operating Income | $197.6M | $212.3M | $240.4M | $239.1M | $233.6M | |
| Net Interest Expenses | $27.7M | $18.8M | $32.1M | $44M | $32M | |
| EBT. Incl. Unusual Items | $118.7M | $190.8M | $205.8M | $234M | $201.4M | |
| Earnings of Discontinued Ops. | -$1.5M | -- | -- | -- | -- | |
| Income Tax Expense | $7M | $25.7M | $32.2M | $26.6M | $29.5M | |
| Net Income to Company | $111.7M | $165.1M | $173.6M | $207.4M | $171.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $110.2M | $165.1M | $173.6M | $207.4M | $171.9M | |
| Basic EPS (Cont. Ops) | $0.27 | $0.46 | $0.49 | $0.59 | $0.50 | |
| Diluted EPS (Cont. Ops) | $0.27 | $0.45 | $0.49 | $0.58 | $0.50 | |
| Weighted Average Basic Share | $338.6M | $359.3M | $353.6M | $351.7M | $341.1M | |
| Weighted Average Diluted Share | $341.7M | $368.4M | $356.5M | $356M | $344.6M | |
| EBITDA | $243.4M | $327.4M | $350.7M | $414.8M | $368.3M | |
| EBIT | $146.4M | $209.6M | $237.9M | $278M | $233.4M | |
| Revenue (Reported) | $1.3B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Operating Income (Reported) | $197.6M | $212.3M | $240.4M | $239.1M | $233.6M | |
| Operating Income (Adjusted) | $146.4M | $209.6M | $237.9M | $278M | $233.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.8B | $819.3M | $709.2M | $1.9B | $813.3M | |
| Short Term Investments | $1.1B | -- | -- | -- | -- | |
| Accounts Receivable, Net | $810.3M | $930.2M | $958.5M | $960.8M | $945.4M | |
| Inventory | $455.5M | $512.7M | $536.7M | $536.9M | $544.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $206.7M | $252.7M | $272.6M | $285.1M | $288.8M | |
| Total Current Assets | $4.4B | $2.5B | $2.5B | $3.7B | $2.6B | |
| Property Plant And Equipment | $610.7M | $395.5M | $421.9M | $439.8M | $433.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $7.4B | $9.2B | $9B | $9.1B | $10.2B | |
| Other Intangibles | $3.3B | $3.9B | $3.5B | $3.2B | $3.3B | |
| Other Long-Term Assets | $344.1M | $512.9M | $455.8M | $518.9M | $494.7M | |
| Total Assets | $16.1B | $16.5B | $15.9B | $16.9B | $17B | |
| Accounts Payable | $480.8M | $557.9M | $623M | $608.6M | $677.4M | |
| Accrued Expenses | $56.9M | $50.2M | $45.3M | $43.4M | $41.6M | |
| Current Portion Of Long-Term Debt | $1.4B | $2.2B | $999.7M | -- | $376.2M | |
| Current Portion Of Capital Lease Obligations | $47M | $44.6M | $38.4M | $37.6M | $36.8M | |
| Other Current Liabilities | $167.8M | $142.2M | $132.5M | $143.8M | $158.4M | |
| Total Current Liabilities | $2.9B | $3.7B | $2.7B | $1.8B | $2.2B | |
| Long-Term Debt | $2.8B | $1.8B | $2.3B | $3.6B | $3.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.1B | $6.9B | $6.2B | $6.6B | $6.8B | |
| Common Stock | $3.4M | $3.6M | $3.6M | $3.6M | $3.7M | |
| Other Common Equity Adj | -$141.1M | -$185M | -$325.7M | -$326.1M | -$465.4M | |
| Common Equity | $9B | $9.5B | $9.7B | $10.3B | $10.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.5M | $4.8M | $5.2M | $6.4M | $7M | |
| Total Equity | $9B | $9.5B | $9.7B | $10.3B | $10.2B | |
| Total Liabilities and Equity | $16.1B | $16.5B | $15.9B | $16.9B | $17B | |
| Cash and Short Terms | $2.9B | $819.3M | $709.2M | $1.9B | $813.3M | |
| Total Debt | $4.2B | $4B | $3.3B | $3.6B | $3.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.3B | $684.3M | $672.8M | $704.6M | $892.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $829.5M | $929M | $940.7M | $962.6M | $929.3M | |
| Inventory | $466.6M | $553.3M | $570.2M | $580.8M | $568M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $205.2M | $281.1M | $271.6M | $365.9M | $314.7M | |
| Total Current Assets | $2.8B | $2.4B | $2.5B | $2.6B | $2.7B | |
| Property Plant And Equipment | $596.7M | $412.6M | $425.6M | $422.7M | $433.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $7.3B | $9.1B | $9.1B | $10.2B | $10.2B | |
| Other Intangibles | $3.2B | $3.8B | $3.4B | $3.7B | $3.3B | |
| Other Long-Term Assets | $331.2M | $484.3M | $470M | $536.2M | $495.8M | |
| Total Assets | $14.3B | $16.3B | $15.8B | $17.5B | $17.1B | |
| Accounts Payable | $464.5M | $576.1M | $593M | $667.2M | $669.3M | |
| Accrued Expenses | $836.9M | $985.7M | $1B | $1.1B | $1.1B | |
| Current Portion Of Long-Term Debt | $1.1B | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $44.6M | -- | -- | -- | -- | |
| Other Current Liabilities | $2.8M | -- | -- | -- | -- | |
| Total Current Liabilities | $2.5B | $2.6B | $2.6B | $1.7B | $2.7B | |
| Long-Term Debt | $1.4B | $2.7B | $2.1B | $3.9B | $2.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.3B | $6.7B | $5.9B | $7B | $6.9B | |
| Common Stock | $3.4M | $3.6M | $3.6M | $3.7M | $3.7M | |
| Other Common Equity Adj | -$174.8M | -$223.9M | -$312.3M | -$402.5M | -$395.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.7M | $5.3M | $5.8M | $6.4M | $6.9M | |
| Total Equity | $9B | $9.6B | $9.9B | $10.5B | $10.2B | |
| Total Liabilities and Equity | $14.3B | $16.3B | $15.8B | $17.5B | $17.1B | |
| Cash and Short Terms | $1.3B | $684.3M | $672.8M | $704.6M | $892.1M | |
| Total Debt | $2.6B | $3.7B | $3.1B | $3.9B | $3.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $614.2M | $755.2M | $865.8M | $832.9M | |
| Depreciation & Amoritzation | $384M | $395.5M | $465.6M | $456.8M | $543.9M | |
| Stock-Based Compensation | $62.6M | $77.4M | $93.8M | $113.3M | $109.2M | |
| Change in Accounts Receivable | $82.4M | -$84.1M | -$52.1M | $9.8M | -$4.5M | |
| Change in Inventories | -$7.3M | -$53.6M | -$40.3M | -$1.7M | $8.8M | |
| Cash From Operations | $1.4B | $961.1M | $1.3B | $1.4B | $1.5B | |
| Capital Expenditures | $75.7M | $50M | $95.8M | $107.8M | $120.4M | |
| Cash Acquisitions | -$40.4M | -$2.6B | -$3.2M | -$95.8M | -$1.7B | |
| Cash From Investing | -$148.4M | -$2.6B | -$102.5M | -$195.4M | -$1.8B | |
| Dividends Paid (Ex Special Dividend) | -$163.4M | -$132.2M | -$99.5M | -$102M | -$111.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $741.7M | $1.4B | $1.4B | $549.3M | $1.7B | |
| Long-Term Debt Repaid | -$2.9B | -$611.1M | -$2.2B | -$1B | -$1B | |
| Repurchase of Common Stock | -- | -- | -$442.9M | -$272.9M | -$889.6M | |
| Other Financing Activities | $1.6B | $30.6M | -$6.7M | $18M | $71.1M | |
| Cash From Financing | -$696.1M | $652M | -$1.3B | $32.3M | -$792.7M | |
| Beginning Cash (CF) | $1.2B | $1.8B | $819.3M | $709.2M | $1.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $592.2M | -$1B | -$72.3M | $1.2B | -$1.1B | |
| Ending Cash (CF) | $1.8B | $819.3M | $709.2M | $1.9B | $813.3M | |
| Levered Free Cash Flow | $1.4B | $911.1M | $1.2B | $1.2B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $111.7M | $165.1M | $173.6M | $207.4M | $171.9M | |
| Depreciation & Amoritzation | $97M | $117.8M | $112.8M | $136.8M | $134.9M | |
| Stock-Based Compensation | $16.6M | $19.9M | $26.7M | $28.9M | $27.5M | |
| Change in Accounts Receivable | -$26.9M | -$1.4M | $21.5M | $8.8M | $31.4M | |
| Change in Inventories | -$3.8M | -$43.2M | -$33.6M | -$13.1M | -$18.1M | |
| Cash From Operations | $144.8M | $214.8M | $174.4M | $256.7M | $241.7M | |
| Capital Expenditures | $8.4M | $18.8M | $24.8M | $26.4M | $26.7M | |
| Cash Acquisitions | -$200K | $900K | -- | -$1.7B | -- | |
| Cash From Investing | -$8.6M | -$17.9M | -$24.8M | -$1.7B | -$26.2M | |
| Dividends Paid (Ex Special Dividend) | -$41M | -$25.1M | -$24.7M | -$28.1M | -$27.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $1.7B | -- | |
| Long-Term Debt Repaid | -$611.1M | -$1.2B | -- | -$1B | -- | |
| Repurchase of Common Stock | -- | -$63.8M | -- | -- | -$202.6M | |
| Other Financing Activities | -$2.8M | -$17.9M | -$3.1M | $25.4M | $8.1M | |
| Cash From Financing | -$654.9M | -$332.6M | -$187.1M | $306.9M | -$141M | |
| Beginning Cash (CF) | $1.8B | $819.3M | $709.2M | $1.9B | $813.3M | |
| Foreign Exchange Rate Adjustment | -$6.5M | $700K | $1.1M | -$10.4M | $4.3M | |
| Additions / Reductions | -$518.7M | -$135.7M | -$37.5M | -$1.2B | $74.5M | |
| Ending Cash (CF) | $1.3B | $684.3M | $672.8M | $704.6M | $892.1M | |
| Levered Free Cash Flow | $136.4M | $196M | $149.6M | $230.3M | $215M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $667.6M | $763.7M | $899.6M | $797.4M | |
| Depreciation & Amoritzation | $382.6M | $416.3M | $460.6M | $480.8M | $542M | |
| Stock-Based Compensation | $66.4M | $80.7M | $100.6M | $115.5M | $107.8M | |
| Change in Accounts Receivable | $49.5M | -$58.6M | -$29.2M | -$2.9M | $18.1M | |
| Change in Inventories | -$5.9M | -$93M | -$30.7M | $18.8M | $3.8M | |
| Cash From Operations | $1.4B | $1B | $1.3B | $1.4B | $1.5B | |
| Capital Expenditures | $57.9M | $60.4M | $101.8M | $109.4M | $120.7M | |
| Cash Acquisitions | -$39.5M | -$2.6B | -$4.1M | -$1.8B | -$14M | |
| Cash From Investing | -$112.8M | -$2.6B | -$109.4M | -$1.9B | -$84.8M | |
| Dividends Paid (Ex Special Dividend) | -$180.9M | -$116.3M | -$99.1M | -$105.4M | -$110.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $367.9M | -- | $1.4B | $2.3B | -$2.9M | |
| Long-Term Debt Repaid | -$3.2B | -$1.2B | -$1B | -$2B | -- | |
| Repurchase of Common Stock | -- | -$63.8M | -- | -$272.9M | -$1.1B | |
| Other Financing Activities | $1.6B | $15.5M | $8.1M | $46.5M | $53.8M | |
| Cash From Financing | -$1.1B | $974.3M | -$1.1B | $526.3M | -$1.2B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $209.9M | -$619.5M | $25.9M | $54.2M | $186.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.3B | $970.7M | $1.2B | $1.3B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $111.7M | $165.1M | $173.6M | $207.4M | $171.9M | |
| Depreciation & Amoritzation | $97M | $117.8M | $112.8M | $136.8M | $134.9M | |
| Stock-Based Compensation | $16.6M | $19.9M | $26.7M | $28.9M | $27.5M | |
| Change in Accounts Receivable | -$26.9M | -$1.4M | $21.5M | $8.8M | $31.4M | |
| Change in Inventories | -$3.8M | -$43.2M | -$33.6M | -$13.1M | -$18.1M | |
| Cash From Operations | $144.8M | $214.8M | $174.4M | $256.7M | $241.7M | |
| Capital Expenditures | $8.4M | $18.8M | $24.8M | $26.4M | $26.7M | |
| Cash Acquisitions | -$200K | $900K | -- | -$1.7B | -- | |
| Cash From Investing | -$8.6M | -$17.9M | -$24.8M | -$1.7B | -$26.2M | |
| Dividends Paid (Ex Special Dividend) | -$41M | -$25.1M | -$24.7M | -$28.1M | -$27.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $1.7B | -- | |
| Long-Term Debt Repaid | -$611.1M | -$1.2B | -- | -$1B | -- | |
| Repurchase of Common Stock | -- | -$63.8M | -- | -- | -$202.6M | |
| Other Financing Activities | -$2.8M | -$17.9M | -$3.1M | $25.4M | $8.1M | |
| Cash From Financing | -$654.9M | -$332.6M | -$187.1M | $306.9M | -$141M | |
| Beginning Cash (CF) | $1.8B | $819.3M | $709.2M | $1.9B | $813.3M | |
| Foreign Exchange Rate Adjustment | -$6.5M | $700K | $1.1M | -$10.4M | $4.3M | |
| Additions / Reductions | -$518.7M | -$135.7M | -$37.5M | -$1.2B | $74.5M | |
| Ending Cash (CF) | $1.3B | $684.3M | $672.8M | $704.6M | $892.1M | |
| Levered Free Cash Flow | $136.4M | $196M | $149.6M | $230.3M | $215M | |
Get FTV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FTV
Sector
P/E ratio
22.49x
18.58x
PEG ratio
4.08x
0.25x
P/B ratio
1.70x
1.75x
Price / LTM sales
2.90x
0.94x
Growth Metrics
FTV
Sector
Revenue growth
-3.3%
1.98%
Earnings growth
-13.79%
2.46%
Revenue (5-year growth)
6.43%
4.35%
Earnings forecast
$0.59
$0.40
Profitability
FTV
Sector
Profitability FY 2024
$3.7B
$393.9M
Return on invested capital
5.6%
5.32%
Return on assets
4.61%
3.49%
Return on equity
7.67%
8.55%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Jul
30
Estimated Next Earnings Date
Jul
31
Balance Sheet
FTV
Sector
Total cash
$892.1M
$154.3M
Short term investments
--
$35.5M
Total assets
$17B
$1.7B
Long term debt
$3.9B
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
